Qualigen
Qualigen is rapidly developing additional desktop blood testing systems for rapid blood tests. Sekisu Diagnostics, LLC a worldwide supplier of diagnostic equipment and compounds, is a major investor in Qualigen. The terms of the partnership deal include that Sekisu funded 100% of the development cost of Qualigen’s new FastPack2.0, third generation system which includes a newly patented technology for blood testing of whole blood samples in small quantities. You can learn more about Qualigen from their website at www.qualigen.com.